Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
About the Project We are seeking a talented and dedicated team of scientists, bioinformaticians and support colleaguesto join the ground-breaking PharosAI initiative – a £43.6M national programme co
-
female Professors in both the Centre for Programming Languages and Systems and the Centre for Intelligent Systems. We strongly welcome applications from women and those from under-represented backgrounds
-
the Immigration, Asylum and Nationality Act 2006. Full Time, Fixed-Term (12 months maternity cover) Applications are invited for the post of Deputy Director (Insight, Planning and Policy) in the Strategic Planning
-
About the Project We are seeking a talented and dedicated team of scientists, bioinformaticians and support colleaguesto join the ground-breaking PharosAI initiative – a £43.6M national programme co
-
About the Role This job is a stakeholder engagement, event management and programme coordination role. A key member of the SEF Professional Services Team, the post holder will be responsible
-
studies and study sites. The successful applicant must possess a postgraduate degree, ideally a doctoral degree, in a relevant topic, expertise in epidemiological knowledge of infectious diseases in humans
-
locally-employed laboratory personnel, ensuring all laboratory activities related to the LSHTM-COMAHS programme and ancillary and future studies are performed in strict accordance to Good Clinical
-
governance activities for LSHTM’s clinical trials. Lead on the strategic development and deployment of robust electronic research data collection solutions, including oversight of application programming. Lead
-
supervised by Dr. Damien Tully and applicants are encouraged to contact Dr. Tully (Damien.Tully@lshtm.ac.uk ) for an informal discussion prior to submitting a formal application. The post-holder will have a
-
– a £43.6M national programme co-led by Queen Mary University of London. PharosAI is set to revolutionise AI-powered cancer care, accelerating the development of breakthrough therapies, advancing